22 research outputs found

    Influência do tratamento intensivo com suporte de peso corporal na função motora de crianças com paralisia cerebral

    Get PDF
    A aquisição da marcha sob o aspecto neuromotor da reabilitação vem a ser o principal desígnio do terapeuta durante a elaboração do plano de tratamento do paciente com paralisia cerebral, uma vez que a marcha representa não só um ganho da habilidade de locomover-se, mas também um conjunto de reações e padrões de movimento que auxiliam na função motora. Objetivo: Analisar os efeitos de um tratamento intensivo por meio do suporte de peso corporal em crianças com paralisia cerebral. Métodos: Participaram do estudo 10 crianças com paralisia cerebral, GMFCS nível IV ou V, idade entre 4 a 9 anos. Onde foram realizadas sessões diárias com suporte de peso corporal em esteira ergométrica com auxílio de terapeutas para executar o padrão de marcha mais próximo da normalidade, com pontos chaves em joelho e tornozelo com duração de 30 minutos de tratamento e intervalo de 24 horas, por um período de 10 dias. Para fins de avaliação pré e pós-intervenção, utilizando a escala de medição da função motora grossa GMFM, e da flexibilidade pelo Flexiteste. Resultados: Foi possível constatar um aumento relevante na função motora grossa dos sujeitos, onde o domínio Deitar e Rolar obteve maior pontuação, com um aumento de 10,77%. Sentar demonstrou aumento de 3,80%, Engatinhar e Ajoelhar 6,43% e o domínio Em Pé 3,45%. Relativo ao Flexiteste, a média entre os sujeitos relatou aumento expressivo de 4,2 pontos. Já em análise individual, percebe-se que 3 indivíduos obtiveram aumento de score de 6 pontos. Conclusão: Um protocolo intensivo de curta duração é capaz de trazer ganhos de flexibilidade e motores rápidos a crianças que possuem quadro de paralisia cerebral.The acquisition of gait under the neuromotor aspect of rehabilitation is the main goal of the therapist during the elaboration of the treatment plan of the patient with cerebral palsy, since gait represents not only a gain in the ability to move, but also a set of reactions and movement patterns that aid in motor function. Objective: To analyze the effects of intensive treatment by means of body weight support in children with cerebral palsy. Method: Ten children with cerebral palsy, GMFCS level IV or V, age between 4 and 9 years participated in the study. Where daily sessions were performed with body weight support on a treadmill with the help of therapists to perform the walking pattern closest to normal, with key points in the knee and ankle lasting 30 minutes of treatment and 24 hour intervals for one period of 10 days. For purposes of pre and post-intervention evaluation, using the GMFM gross motor function measurement scale, and Flexitest flexibility. Results: It was possible to observe a significant increase in the gross motor function of the subjects, where the lie down and roll domain obtained a higher score, with an increase of 10.77%. To sit demonstrated a 3.80% increase, Crawling and Kneeling 6.43% and the Standing Foot 3.45%. Relative to Flexitest, the mean between subjects reported a significant increase of 4.2 points. In the individual analysis, it was observed that 3 subjects had a 6-point score increase. Conclusions: An intensive short-duration protocol is capable of bringing flexibility gains and fast motor to children with cerebral palsy

    Administration of Harmine and Imipramine Alters Creatine Kinase and Mitochondrial Respiratory Chain Activities in the Rat Brain

    Get PDF
    The present study evaluated mitochondrial respiratory chain and creatine kinase activities after administration of harmine (5, 10, and 15 mg/kg) and imipramine (10, 20, and 30 mg/kg) in rat brain. After acute treatment occurred an increase of creatine kinase in the prefrontal with imipramine (20 and 30 mg/kg) and harmine in all doses, in the striatum with imipramine (20 and 30 mg/kg) and harmine (5 and 10 mg/kg); harmine (15 mg/kg) decreased creatine kinase. In the chronic treatment occurred an increase of creatine kinase with imipramine (20 mg/kg), harmine (5 mg/kg) in the prefrontal with imipramine (20 and 30 mg/kg) and harmine (5 and 10 mg/kg) in the striatum. In the acute treatment, the complex I increased in the prefrontal with harmine (15 mg/kg) and in the striatum with harmine (10 mg/kg); the complex II decreased with imipramine (20 and 30 mg/kg) in the striatum; the complex IV increased with imipramine (30 mg/kg) in the striatum. In the chronic treatment, the complex I increased with harmine (5 mg/kg) in the prefrontal; the complex II increased with imipramine (20 mg/kg) in the prefrontal; the complex IV increased with harmine (5 mg/kg) in the striatum. Finally, these findings further support the hypothesis that harmine and imipramine could be involved in mitochondrial function

    Case report: a typical Silver-Russell syndrome patient with hand dystonia: the valuable support of the consensus statement to the wide syndromic spectrum

    Get PDF
    The amount of Insulin Growth Factor 2 (IGF2) controls the rate of embryonal and postnatal growth. The IGF2 and adjacent H19 are the imprinted genes of the telomeric cluster in the 11p15 chromosomal region regulated by differentially methylated regions (DMRs) or imprinting centers (ICs): H19/IGF2:IG-DMR (IC1). Dysregulation due to IC1 Loss-of-Methylation (LoM) or Gain-of-Methyaltion (GoM) causes Silver–Russell syndrome (SRS) or Beckwith–Wiedemann syndrome (BWS) disorders associated with growth retardation or overgrowth, respectively. Specific features define each of the two syndromes, but isolated asymmetry is a common cardinal feature, which is considered sufficient for a diagnosis in the BWS spectrum. Here, we report the case of a girl with right body asymmetry, which suggested BWS spectrum. Later, BWS/SRS molecular analysis identified IC1_LoM revealing the discrepant diagnosis of SRS. A clinical re-evaluation identified a relative macrocephaly and previously unidentified growth rate at lower limits of normal at birth, feeding difficulties, and asymmetry. Interestingly, and never previously described in IC1_LoM SRS patients, since the age of 16, she has developed hand-writer’s cramps, depression, and bipolar disorder. Trio-WES identified a VPS16 heterozygous variant [NM_022575.4:c.2185C>G:p.Leu729Val] inherited from her healthy mother. VPS16 is involved in the endolysosomal system, and its dysregulation is linked to autosomal dominant dystonia with incomplete penetrance and variable expressivity. IGF2 involvement in the lysosomal pathway led us to speculate that the neurological phenotype of the proband might be triggered by the concurrent IGF2 deficit and VPS16 alteration

    Fetal cell microchimerism: a protective role in autoimmune thyroid diseases

    No full text
    The physiological persistence of fetal cells in the circulation and tissue of a previously pregnant woman is called fetal cell microchimerism (FCM). It has been hypothesized to play a role in systemic autoimmune disease; however, only limited data are available regarding its role in autoimmune thyroid disease (AITD)

    Constitutional de novo deletion of the FBXW7 gene in a patient with focal segmental glomerulosclerosis and multiple primitive tumors

    Get PDF
    Multiple primary malignant neoplasms are rare entities in the clinical setting, but represent an important issue in the clinical management of patients since they could be expression of a genetic predisposition to malignancy. A high resolution genome wide array CGH led us to identify the first case of a de novo constitutional deletion confined to the FBXW7 gene, a well known tumor suppressor, in a patient with a syndromic phenotype characterized by focal segmental glomerulosclerosis and multiple primary early/atypical onset tumors, including Hodgkin's lymphoma, Wilms tumor and breast cancer. Other genetic defects may be associated with patient's phenotype. In this light, constitutional mutations at BRCA1, BRCA2, TP53, PALB2 and WT1 genes were excluded by performing sequencing and MLPA analysis; similarly, we ruled out constitutional abnormalities at the imprinted 11p15 region by methylation specific -MLPA assay. Our observations sustain the role of FBXW7 as cancer predisposition gene and expand the spectrum of its possible associated diseases

    DataSheet2_Case report: a typical Silver-Russell syndrome patient with hand dystonia: the valuable support of the consensus statement to the wide syndromic spectrum.xlsx

    No full text
    The amount of Insulin Growth Factor 2 (IGF2) controls the rate of embryonal and postnatal growth. The IGF2 and adjacent H19 are the imprinted genes of the telomeric cluster in the 11p15 chromosomal region regulated by differentially methylated regions (DMRs) or imprinting centers (ICs): H19/IGF2:IG-DMR (IC1). Dysregulation due to IC1 Loss-of-Methylation (LoM) or Gain-of-Methyaltion (GoM) causes Silver–Russell syndrome (SRS) or Beckwith–Wiedemann syndrome (BWS) disorders associated with growth retardation or overgrowth, respectively. Specific features define each of the two syndromes, but isolated asymmetry is a common cardinal feature, which is considered sufficient for a diagnosis in the BWS spectrum. Here, we report the case of a girl with right body asymmetry, which suggested BWS spectrum. Later, BWS/SRS molecular analysis identified IC1_LoM revealing the discrepant diagnosis of SRS. A clinical re-evaluation identified a relative macrocephaly and previously unidentified growth rate at lower limits of normal at birth, feeding difficulties, and asymmetry. Interestingly, and never previously described in IC1_LoM SRS patients, since the age of 16, she has developed hand-writer’s cramps, depression, and bipolar disorder. Trio-WES identified a VPS16 heterozygous variant [NM_022575.4:c.2185C>G:p.Leu729Val] inherited from her healthy mother. VPS16 is involved in the endolysosomal system, and its dysregulation is linked to autosomal dominant dystonia with incomplete penetrance and variable expressivity. IGF2 involvement in the lysosomal pathway led us to speculate that the neurological phenotype of the proband might be triggered by the concurrent IGF2 deficit and VPS16 alteration.</p
    corecore